Navigation Links
Merck Serono Completes Enrollment in the REFLEX Trial of Rebif(R) in Patients at Risk of Developing Multiple Sclerosis
Date:9/16/2008

roven effective in all three key measures of treatment effectiveness: MRI lesion area and activity*, relapse rates and disability progression. The safety profile of Rebif(R) is supported by a robust, ongoing clinical development and post-marketing program and a 10-year record of use by MS patients.

The REFLEX trial is being conducted with the new formulation of Rebif(R). The new formulation of Rebif(R) was approved in the European Union in August 2007 and in Canada in September 2007 and is now marketed in all EU countries and in Canada. The new formulation of Rebif(R) is not available in the United States.

* The exact correlation between MRI findings and the current or future clinical status of patients, including disability progression, is unknown.

About Rebif(R)

Rebif(R) (interferon beta-1a) is a disease-modifying drug used to treat relapsing forms of multiple sclerosis (MS) and is similar to the interferon beta protein produced by the human body. The efficacy of Rebif(R) in chronic progressive MS has not been established. Interferons are thought to help modulate the body's immune system and reduce inflammation. The exact mechanism is unknown.

Rebif(R), which was approved in Europe in 1998 and in the US in 2002, is registered in more than 80 countries worldwide. Rebif(R) has been proven to delay the progression of disability, reduce the frequency of relapses and reduce MRI lesion activity and area*. Rebif(R) is available in a 22 micrograms and 44 micrograms ready-to-use pre-filled syringe and a titration pack (8.8 micrograms).

Rebif(R) should be used with caution in patients with a history of depression, liver disease and seizures. Most commonly reported side effects are flu-like symptoms, injection site disorders, elevation of liver enzymes and blood cell abnormalities. Patients, especially those with depression, seizure disorders, or liver problems, should discuss treatment with Rebif(R) with their doctors. For more info
'/>"/>

SOURCE Merck Serono International S A
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Diakron Licenses Anticoagulant Drug Candidate from Merck & Co., Inc.
2. MicroDose Technologies Announces Achievement of Phase I Clinical Milestone Triggering First Milestone Payment Under Collaboration with Merck & Co., Inc.
3. NicOx Announces Initiation of First Phase 1 Study of Investigational Nitric Oxide-Donating Agent in Hypertensive Patients by Merck & Co., Inc.
4. Iomai and Merck & Co., Inc. Evaluate Use of Iomai Immunostimulant Patch
5. Microbicide Developer Receives License for Novel HIV Microbicide Candidate From Merck & Co., Inc.
6. Parker Waichman Alonso LLP and Affiliated Lawfirms Have Filed a Class Action Lawsuit in the United States District Court for the Eastern District of New York Against Merck & Co., Inc. and Schering-Plough Corporation
7. Ambrx Enters FGF-21 Type 2 Diabetes Drug Discovery Collaboration with Merck and Co. Inc.
8. MJFF and Merck Serono (EMD Serono in North America) Join Forces on $2-Million Initiative to Drive Treatments for PD-Related Cognitive Dysfunction and Mood Disorders
9. GeoVax Labs, Inc. Comments on Discontinuance of Mercks HIV Vaccine Trial
10. Merck/Gilead Once-A-Day AIDS Pill Not Available in Most Places - AHF Urges Speed-Up of Registrations
11. CuraGen Completes Enrollment in Phase II Trial of CR011-vcMMAE in Metastatic Melanoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)... 3, 2015 ReportsnReports.com adds ... with 2020 forecasts as well as Global Medical ... devices intelligence collection of its library. ... 2020 forecasts spread across 164 pages, talking about ... and figures is now available at http://www.reportsnreports.com/reports/407046-global-medical-simulation-industry-report-2015.html ...
(Date:8/3/2015)... , Aug. 3, 2015  Depomed, Inc. (NASDAQ: ... on Horizon Pharma plc,s (NASDAQ: HZNP ) ("Horizon") ... of Directors ("Depomed Board") set a record date to ... The Depomed Board will review the ... is received today and contains the information required under ...
(Date:8/3/2015)... , Aug. 3, 2015  Dr. Cal ... Orthopaedic & Spine Center today, providing patients ... their chronic pain through psychological counseling and treatment ... a Fellowship-trained, certified medical psychologist with an extensive ... vast experience ranges from assessment and treatment of ...
Breaking Medicine Technology:Medical Simulation Market to see 14% CAGR to 2019 2Medical Simulation Market to see 14% CAGR to 2019 3Medical Simulation Market to see 14% CAGR to 2019 4Medical Simulation Market to see 14% CAGR to 2019 5Medical Simulation Market to see 14% CAGR to 2019 6Depomed Comments on Horizon Pharma Announcement 2Depomed Comments on Horizon Pharma Announcement 3Depomed Comments on Horizon Pharma Announcement 4Depomed Comments on Horizon Pharma Announcement 5Depomed Comments on Horizon Pharma Announcement 6Orthopaedic & Spine Center Introduces New Pain Psychologist 2
... June 2, 2011 Craneware, Inc., the market ... new multi-year agreement today with Kingman Regional Medical ... AZ. Recognized as one of the nation,s five ... Center will add Craneware InSight Denials® to the ...
... 2011 Syndax Pharmaceuticals, a clinical-stage epigenetics oncology ... Patent and Trademark Office of Patent Application Serial ... B."   This follows the UK issuance which ... the extensive patent estate. The patent ...
Cached Medicine Technology:Kingman Adds Craneware Revenue Integrity Solution - InSight Denials® 2Kingman Adds Craneware Revenue Integrity Solution - InSight Denials® 3Kingman Adds Craneware Revenue Integrity Solution - InSight Denials® 4Syndax Pharmaceuticals Announces Issuance of US Patent for Entinostat 2Syndax Pharmaceuticals Announces Issuance of US Patent for Entinostat 3
(Date:8/4/2015)... ... August 04, 2015 , ... Isabel Healthcare and ... Symptom Checker available to all users of the KHIN personal health record, MyKSHealtheRecords.org. ... in an easy, intuitive method, provides access to material on possible conditions and ...
(Date:8/3/2015)... (PRWEB) , ... August 04, 2015 , ... While the pace of the economic recovery ... States has clearly been on a growth trajectory for the last six years. Unemployment has ... and is trending at a 3.5 percent growth rate in 2014, the U.S. stock market ...
(Date:8/3/2015)... TX (PRWEB) , ... August 04, 2015 , ... ... convenient and affordable online CE courses for rehabilitation professionals, HomeCEUConnection.com today announced extra ... professionals in Florida can now take advantage of big savings on Physical ...
(Date:8/3/2015)... ... ... Master offers the most affordable web design and SEO services for start up companies. ... their dollar. Every company that is starting out needs to be online in this ... does a start up need to be online, they need to physically be present and ...
(Date:8/3/2015)... , ... August 03, 2015 , ... Sutter Health’s California ... operating officer (COO) at CPMC. Hamila will start in her role effective immediately and ... , Kownacki has worked at CPMC and Sutter Health for about 15 years, including ...
Breaking Medicine News(10 mins):Health News:Isabel Healthcare Partners with the Kansas Health Information Network, Inc. to Deploy Isabel Symptom Checker within the MyKSHealth eRecord Personal Health Record 2Health News:Isabel Healthcare Partners with the Kansas Health Information Network, Inc. to Deploy Isabel Symptom Checker within the MyKSHealth eRecord Personal Health Record 3Health News:Newport Board group, an Advisory Firm Serving the Middle Market, Cautions Businesses on How to Survive the Coming Recession 2Health News:Newport Board group, an Advisory Firm Serving the Middle Market, Cautions Businesses on How to Survive the Coming Recession 3Health News:Newport Board group, an Advisory Firm Serving the Middle Market, Cautions Businesses on How to Survive the Coming Recession 4Health News:Elite Online CE Provider Offers Discounted Flexible Packages to Meet Florida Physical Therapy Continuing Education Requirements 2Health News:Web SEO Master, a division of SH Web Design & SH Web Commerce, Inc. begins offering Web Design and SEO Services for Start Up Companies located in Indianapolis, Indiana 2Health News:Web SEO Master, a division of SH Web Design & SH Web Commerce, Inc. begins offering Web Design and SEO Services for Start Up Companies located in Indianapolis, Indiana 3Health News:Hamila Kownacki, RN Appointed as New Chief Operating Officer at CPMC 2
... new study by specialists at the Johns Hopkins Children’s ... inner-city children with chronic asthma //gets enough medicine to ... reported in December's Pediatrics, are disturbing, the researchers say, ... 'rescue' drugs after an asthma attack strikes and to ...
... The American Dental association announced on the 9th of November, ... preparation of infant formulation. // ,The dentists are concerned ... might be disastrous as instead of protecting teeth it might ... lead to weakened bones and even bone cancer boys. ...
... and Improvement suggested that some patients should be cared for ... them in the hospital wards. ,The draft ... and Emergency (A&E) departments that leads to hospital admissions and ... admitted in hospital wards. ,Home treatments ...
... in a gene known as SOS1 account for many ... //disorder which occurs in one in 1,000-2,500 live births. ... learning disabilities, as well as heart problems and predisposition ... School-Partners Healthcare Center for Genetics and Genomics (HPCGG) and ...
... of dubious consolation, nineteen persons infected with AIDS will ... most moneyed lawsuit//. This money should provide some relief ... them are living in poverty. ,Fifteen persons were ... at a provincial hospital of northern China in 2004. ...
... programme has been working effectively and the same has ... UNAIDS has not informed the Government about any award ... prevention amongst the services. ,The incidence of ... 2005 was 0.028%. ,No disciplinary action is ...
Cached Medicine News:Health News:City Kids With Asthma Lose Out on Preventive Treatment 2Health News:Study Uncovers Mutation Responsible for Noonan Syndrome 2
... Instrument System. It is the only instrument ... power with the unparalleled high performance that ... advanced design of this instrument system provides ... system, advanced control circuitry, and the versatility ...
... Performance Instrument System was developed ... increased power of the Neurosurgeon ... provides 60% more torque than ... handle the most demanding craniotomies ...
Legend Gold is the most powerful of the new motors. It runs at an impressive 76,000 rpm at 120 psi/8 bar. It is also smaller than the Midas Rex Classic motor, with an enhanced ergonomic design....
Circular Spine Retractor System for microsurgical interventions in the lumbar and cervical spine region. The system has been approved in over 120 cases....
Medicine Products: